PD-1 mRNA expression is associated with clinical and viral profile and PD1 3'-untranslated region polymorphism in patients with chronic HBV infection

Immunology Letters

Volumn 162, Issue 1, 2014, Pages 212-216

  Zhang, Guoyu ^a   Li, Na ^a   Zhang, Pingping ^a   Li, Fang ^a   Yang, Cuiling ^a   Zhu, Qianqian ^a   Han, Qunying ^a   Lv, Yi ^a   Zhou, Zhihua ^a   Liu, Zhengwen ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

3' untranslated region; Chronic infection; Hepatitis B virus; Programmed cell death 1; Single nucleotide polymorphism

Indexed keywords

HEPATITIS B(E) ANTIGEN; MESSENGER RNA; PROGRAMMED DEATH 1 RECEPTOR; VIRUS DNA; 3' UNTRANSLATED REGION;

3' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGRAMMED DEATH 1 RECEPTOR GENE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETICS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MIDDLE AGED; VIROLOGY; VIRUS LOAD; VIRUS REPLICATION; YOUNG ADULT;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; ALLELES; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGRAMMED CELL DEATH 1 RECEPTOR; RNA, MESSENGER; VIRAL LOAD; VIRUS REPLICATION; YOUNG ADULT;

EID: 84908266250     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.09.001     Document Type: Article

References (25)

1. McMahon B.J. The natural history of chronic hepatitis B virus infection. Semin Liver Dis 2004, 24:17-21.
2. Ganem D., Prince A.M. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004, 350:1118-1129.
3. European Association For The Study Of The Liver EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2012, 57:167-185.
4. Lok A.S., McMahon B.J. Chronic hepatitis B. Hepatology 2007, 45:507-539.
5. Boni C., Fisicaro P., Valdatta C., Amadei B., Di Vincenzo P., Giuberti T., et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 2007, 81:4215-4225.
6. Peng G., Li S., Wu W., Tan X., Chen Y., Chen Z. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. Mol Immunol 2008, 45:963-970.
7. Zhang Z., Zhang J.Y., Wherry E.J., Jin B., Xu B., Zou Z.S., et al. Dynamic programmed death 1 expression by virus-specific CD8T cells correlates with the outcome of acute hepatitis B. Gastroenterology 2008, 134:1938-1949.
8. Fisicaro P., Valdatta C., Massari M., Loggi E., Biasini E., Sacchelli L., et al. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 2010, 138:682-693.
9. Zeng Z., Shi F., Zhou L., Zhang M.N., Chen Y., Chang X.J., et al. Upregulation of circulating PD-L1/PD-1 is associated with poor post-cryoablation prognosis in patients with HBV-related hepatocellular carcinoma. PLoS One 2011, 6:e23621.
10. Hou F.Q., Wu X.J., Wang Y., Chen J., Liu Y.Z., Ren Y.Y., et al. Rapid downregulation of programmed death-1 and interferon-γ-inducible protein-10 expression is associated with favourable outcome during antiviral treatment of chronic hepatitis B. J Viral Hepatitis 2013, 20(Suppl 1):18-26.
11. Zhang G., Liu Z., Duan S., Han Q., Li Z., Lv Y., et al. Association of polymorphisms of programmed cell death-1 gene with chronic hepatitis B virus infection. Hum Immunol 2010, 71:1209-1213.
12. Li Z., Li N., Zhu Q., Zhang G., Han Q., Zhang P., et al. Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection. Infect Genet Evol 2013, 14:240-246.
13. Chinese Society of Infectious Diseases and Parasitology and the Chinese Society of Hepatology Proposal of prevention and treatment of viral hepatitis. Zhonghua Nei Ke Za Zhi (Chin J Intern Med) 2001, 40:62-68.
14. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
15. Yang H.I., Lu S.N., Liaw Y.F., You S.L., Sun C.A., Wang L.Y., et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002, 347:168-174.
16. Liang T.J., Ghany M., Hepatitis B. e Antigen-the dangerous endgame of hepatitis B. N Engl J Med 2002, 347:208-210.
17. Ye P., Weng Z.H., Zhang S.L., Zhang J.A., Zhao L., Dong J.H., et al. Programmed death-1 expression is associated with the disease status in hepatitis B virus infection. World J Gastroenterol 2008, 14:4551-4557.
18. Li M., Sun X.H., Zhu X.J., Jin S.G., Zeng Z.J., Zhou Z.H., et al. HBcAg induces PD-1 upregulation on CD4+T cells through activation of JNK, ERK and PI3K/AKT pathways in chronic hepatitis-B-infected patients. Lab Invest 2012, 92:295-304.
19. Evans A., Riva A., Cooksley H., Phillips S., Puranik S., Nathwani A., et al. PD-1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion. Hepatology 2008, 48:759-769.
20. Hsu P.N., Yang T.C., Kao J.T., Cheng K.S., Lee Y.J., Wang Y.M., et al. Increased PD-1 and decreased CD28 expression in chronic hepatitis B patients with advanced hepatocellular carcinoma. Liver Int 2010, 30:1379-1386.
21. Iloeje U.H., Yang H.I., Su J., Jen C.L., You S.L., Chen C.J. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006, 130:678-686.
22. Chen C.J., Yang H.I., Su J., Jen C.L., You S.L., Lu S.N., et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006, 295:65-73.
23. Lee M.H., Yang H.I., Liu J., Batrla-Utermann R., Jen C.L., Iloeje U.H., et al. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles. Hepatology 2013, 58:546-554.
24. Maier H., Isogawa M., Freeman G.J., Chisari F.V. PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver. J Immunol 2007, 178:2714-2720.
25. Tzeng H.T., Tsai H.F., Liao H.J., Lin Y.J., Chen L., Chen P.J., Hsu P.N. PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model. PLoS One 2012, 7:e39179.